The event brought together delegates from 24 countries to discuss the Indian Pharmacopoeia and the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP).

Key discussions focused on enhancing access to affordable medicines, strengthening regulatory systems, and promoting health coverage schemes like Jan Aushadhi Kendras.

Technical sessions showcased India’s advancements in drug regulation, while field visits to laboratories, pharmacies, and manufacturing units offered insights into India’s pharmaceutical infrastructure.

The forum highlighted India’s contributions to generic drug and vaccine supply and reinforced its commitment to equitable global healthcare through capacity-building, quality standards, and stronger international partnerships